Alopecia areata: The need for guidelines and evidence-based dermatology [16]

British Journal of Dermatology

Volumn 152, Issue 5, 2005, Pages 1086-1087

  Sladden, M J ^a   Macdonald Hull, S P ^b   Wood, M L ^c   Hutchinson, P E ^a   Messenger, A G ^d  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b Pontefract General Infirmary   (United Kingdom)

^c ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ALOPECIA AREATA; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; LETTER; MEDICAL EXPERT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMIC THERAPY;

ALOPECIA AREATA; DERMATOLOGY; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES;

EID: 18944386160     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06578.x     Document Type: Letter

References (5)

1. Bunker CB. Systemic steroids in the treatment of alopecia areata. Br J Dermatol 2004; 151:246-7.
2. MacDonald Hull S, Wood M, Hutchinson P et al. Guidelines for the management of alopecia areata. Br J Dermatol 2003; 149:692-9.
3. Royal College of Physicians of London, http://www.rcplondon.ac.uk/ college/ceeu/ceeu_guidelinesdb.asp (Accessed December 2004).
4. Cox NH, Williams HC. The British Association of Dermatologists therapeutic guidelines: can we AGREE? Br J Dermatol 2003; 148:621-5.
5. Sackett DL. Evidence-based medicine. Semin Perinato 1997; 21:3-5.